Market Research Reports

  The cell and gene therapy market is the upcoming wave of therapeutic innovation in the healthcare and life sciences industry. However, the technology for manufacturing these therapies are still in t nascent stage. Furthermore, in 2020 significant number of financing was received by the company for cell and gene therapies in spite of economic challenges due to COVID-19 spread. The year was record breaking and the therapeutic developers of the cell and gene therapies raised more in the first half of the year than in the complete year 2019.  Cell and gene therapy are overlapping fields of biomedical research having similar therapeutic goals, which target DNA or RNA inside or outside the body. Both therapies aim at modifying genetic material for treatment of a disease. Gene therapy uses genetic material, or DNA, to manipulate a patient’s cells for the treatment of an inherited or acquired disease. Cell therapy is the introduction of new cells into a patient’s body to grow, replace or rep

  The global operating room (OR) management solutions market is a huge market comprised of various software solutions that are used in an operating room. These include solutions for data management, inventory management, scheduling and planning of surgeries, communication among surgical staff within and outside the OR, and improved visualization, reporting, and documentation, among others. The global  operating room management solutions market  report highlights that the market was valued at $2,023.5 million in 2021 and is expected to reach $3,699.1 million by the end of 2031. The market is expected to grow at a CAGR of 6.29% during the forecast period from 2022 to 2031.   Impact of COVID-19 on the Operating Room Management Solutions Market The COVID-19 pandemic led to a deferral of elective surgeries across various clinical areas, such as neurology and cardiology. The pandemic also placed heightened importance on the safety and sterilization protocols followed by the medical instituti

  The endoscopic imaging market has witnessed significant advancements over the past few years. It is anticipated to grow significantly during the forecast period owing to the growing adoption of minimally invasive procedures, the improving clinical quality of the endoscopic procedures, and the rising technology integration in endoscopic imaging systems. The  global endoscopic imaging systems market   is projected to reach  $6.94 billion  in terms of revenue by 2030, at a CAGR of 7.43%, suggests the premium market intelligence study by BIS Research. The comprehensive study of the global endoscopic imaging systems market by BIS Research extensively covers the market numbers based on the types of applications and region. It analyzes 15 companies offering endoscopic imaging systems along with a detailed global and regional market analysis, including the scrutiny of 10 key countries. Recent Developments in Global Endoscopic Imaging Systems Market •    In October 2021, Fujifilm Healthcare A

  Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis/profiling being a key tool in this sector. Due to increasing demands on time and resources, human identification and forensics labs are under constant pressure to increase the efficiency of their workflows without sacrificing quality. Examining the variety of biological indicators that are available to investigators illustrates the basic principles of each process in criminal investigation and paternity identification. While DNA and fingerprints are clearly the favored methods of identification, they require a prior record and verifiable baseline for comparison. The global  human identification market   is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032. The growth in the global human identification market is expected to be driven by the inc

  The global narcolepsy therapeutics market is in the rapidly evolving and dynamic stage, which opens ample opportunities for life science companies. Also, companies that are already in the development phase for narcolepsy therapies are trying to bring advanced treatment options to the market to improve the quality of life of people with narcolepsy. The companies operating in the global narcolepsy therapeutics market are now focusing more on disease-specific and personalized treatment options. Also, major players such as Jazz Pharmaceuticals PLC, Takeda Pharmaceuticals Co. Ltd, and Bioproject Pharma are investing heavily in research and development for their respective therapeutic products. The global  narcolepsy therapeutics market  is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032. This The market is driven by certain factors, such as low satisfaction with available therapies, robust pipeline products,

  The global digital biomanufacturing market is a huge market comprised of various software and platforms that include process analytical technologies, data analytics software, ai and IoMT solutions, predictive analytics and digital twin technologies, and others. If application is involved, we have bioprocess optimization and process analytics, biomanufacturing process automation and control, and flexible manufacturing. The innovations of digital technologies have introduced various levels of shifts in manufacturing sectors. The digitalization waves have supported a wide range of applications, from upstream supply chain management to post-manufacturing product tracing and tracking.The global digital biomanufacturing market will be witnessing growth due to the inclusion of new technology trends. Any new market players that enter the market will have to have these technologies to compete in the market and to make a place and gain a strong hold. The global   digital biomanufacturing marke

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in the development of